Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""hypertension"" wg kryterium: Temat


Starter badań:

Tytuł:
Tyvaso DPI: Drug-device characteristics and patient clinical considerations.
Autorzy:
McEvoy C; Division of Pulmonary and Critical Care Medicine, Washington University in St. Louis, St. Louis, MO, USA.
Argula R; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, USA.
Sahay S; Division of Pulmonary, Critical Care & Sleep Medicine, Houston Methodist Hospital, Houston, TX, USA.
Shapiro S; Cardiology Division, Greater Los Angeles VA Healthcare System, Department of Pulmonary Critical Care, David Geffen UCLA School of Medicine, Los Angeles, CA, USA.
Eagan C; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, FL, USA.
Hickey AJ; RTI International, Research Triangle Park, NC, USA.
Smutney C; MannKind Corporation, Danbury, CT, USA.
Dillon C; United Therapeutics Corporation, Research Triangle Park, NC, USA.
Winkler T; United Therapeutics Corporation, Research Triangle Park, NC, USA.
Davis BN; United Therapeutics Corporation, Research Triangle Park, NC, USA.
Broderick M; United Therapeutics Corporation, Research Triangle Park, NC, USA.
Burger C; Division of Pulmonary, Allergy and Sleep Medicine, Mayo Clinic, Jacksonville, FL, USA. Electronic address: .
Pokaż więcej
Źródło:
Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2023 Dec; Vol. 83, pp. 102266. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hypertension, Pulmonary*/drug therapy
Pulmonary Arterial Hypertension*
Humans ; Dry Powder Inhalers ; Pharmaceutical Preparations ; Epoprostenol/adverse effects ; Administration, Inhalation ; Familial Primary Pulmonary Hypertension/drug therapy
Czasopismo naukowe
Tytuł:
Computed tomographic findings in TBX4 mutation: a common cause of severe pulmonary artery hypertension in children.
Autorzy:
Neves da Silva HV; Department of Radiology, Children's Hospital Colorado, Aurora, CO, USA. .; University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA. .; Department of Internal Medicine, Alameda Health System, Highland Hospital, Oakland, CA, USA. .
Weinman JP; Department of Radiology, Children's Hospital Colorado, Aurora, CO, USA.; University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.
Englund EK; Department of Radiology, Children's Hospital Colorado, Aurora, CO, USA.
Deterding RR; University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.; The Breathing Institute, Children's Hospital Colorado, Aurora, CO, USA.
Ivy DD; University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.; The Heart Institute, Children's Hospital Colorado, Aurora, CO, USA.
Browne LP; Department of Radiology, Children's Hospital Colorado, Aurora, CO, USA.; University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.
Pokaż więcej
Źródło:
Pediatric radiology [Pediatr Radiol] 2024 Feb; Vol. 54 (2), pp. 199-207. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*/diagnostic imaging
Hypertension, Pulmonary*/genetics
Female ; Humans ; Child ; Infant ; Child, Preschool ; Adolescent ; Retrospective Studies ; Pulmonary Artery ; Familial Primary Pulmonary Hypertension/genetics ; Mutation ; Tomography, X-Ray Computed ; T-Box Domain Proteins/genetics
Czasopismo naukowe
Tytuł:
Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes.
Autorzy:
Loponen N; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.
Ylä-Outinen H; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.; Department of Pulmonary Diseases, Turku University Hospital, Turku, Finland.
Kallionpää RA; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.
Valtanen M; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.; Department of Mathematics and Statistics, University of Turku, Turku, Finland.; Department of Public Health and Welfare, Population Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Auranen K; Department of Mathematics and Statistics, University of Turku, Turku, Finland.; Department of Clinical Medicine, University of Turku, Turku, Finland.
Järveläinen H; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.; Department of Internal Medicine, Satakunta Central Hospital, Pori, Finland.
Peltonen S; Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland.; Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Peltonen J; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.
Pokaż więcej
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2024 Jan; Vol. 12 (1), pp. e2346. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Journal Article
MeSH Terms:
Neurofibromatosis 1*/diagnosis
Hypertension*/epidemiology
Male ; Humans ; Female ; Essential Hypertension/epidemiology ; Essential Hypertension/complications ; Risk Factors ; Finland/epidemiology
Czasopismo naukowe
Tytuł:
Angiotensin-Converting Enzyme 2 (ACE2) Signaling in Pulmonary Arterial Hypertension: Underpinning Mechanisms and Potential Targeting Strategies.
Autorzy:
Papavassiliou KA; First University Department of Respiratory Medicine, 'Sotiria' Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Gogou VA; First University Department of Respiratory Medicine, 'Sotiria' Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Papavassiliou AG; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 13; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*/drug therapy
Humans ; Angiotensin-Converting Enzyme 2/therapeutic use ; Peptidyl-Dipeptidase A/metabolism ; Familial Primary Pulmonary Hypertension ; Receptors, G-Protein-Coupled/metabolism ; Angiotensin I/metabolism ; Peptide Fragments/metabolism ; Renin-Angiotensin System
Czasopismo naukowe
Tytuł:
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).
Autorzy:
Charoenpong P; Internal Medicine, Division of Pulmonary and Critical Care, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.; Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.; Louisiana Addition Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Dhillon N; Internal Medicine, Pulmonary and Critical Care, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Murnane K; Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.; Louisiana Addition Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.; Department of Pharmacology Toxicology and Neuroscience, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.; Department of Psychiatry, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
Goeders N; Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.; Louisiana Addition Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.; Department of Pharmacology Toxicology and Neuroscience, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.; Department of Psychiatry, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
Hall N; Department of Pharmacology Toxicology and Neuroscience, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
Keller C; Department of Pharmacology Toxicology and Neuroscience, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
Bhuiyan MAN; Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.; Internal Medicine, Division of Clinical Informatics, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
Walter R; Internal Medicine, Division of Pulmonary and Critical Care, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA .; Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.; Louisiana Addition Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Pokaż więcej
Źródło:
BMJ open respiratory research [BMJ Open Respir Res] 2023 Dec 07; Vol. 10 (1). Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*/chemically induced
Pulmonary Arterial Hypertension*/epidemiology
Pulmonary Arterial Hypertension*/complications
Hypertension, Pulmonary*/epidemiology
Hypertension, Pulmonary*/etiology
Humans ; Male ; Female ; Familial Primary Pulmonary Hypertension/complications ; Cross-Sectional Studies ; Biological Specimen Banks
Czasopismo naukowe
Tytuł:
Evaluation of maternal-fetal outcomes in pregnancy complicated with severe pulmonary hypertension and its influencing factors: a single-center retrospective study in China.
Autorzy:
Dai Q; Department of Obstetrics and Gynecology, Fujian Medical University Union Hospital, Fuzhou, China.
Shang M; School of Public Health, Fujian Medical University, Fuzhou, China.
Zhou Y; Department of Obstetrics and Gynecology, Fujian Medical University Union Hospital, Fuzhou, China.
Wei Q; Department of Medical Administration, Fujian Medical University Union Hospital, Fuzhou, China.
Pokaż więcej
Źródło:
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians [J Matern Fetal Neonatal Med] 2023 Dec; Vol. 36 (2), pp. 2290923. Date of Electronic Publication: 2023 Dec 06.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension, Pulmonary*/etiology
Hypertension, Pulmonary*/complications
Pulmonary Arterial Hypertension*/complications
Premature Birth*/epidemiology
Heart Defects, Congenital*/complications
Heart Failure*
Infant ; Female ; Pregnancy ; Infant, Newborn ; Humans ; Retrospective Studies ; Cesarean Section/adverse effects ; Familial Primary Pulmonary Hypertension/complications ; Parturition ; Pregnancy Outcome/epidemiology
Czasopismo naukowe
Tytuł:
Comprehensive analysis of m A methylomes in idiopathic pulmonary arterial hypertension.
Autorzy:
Huang T; Department of Ultrasound, Hunan Children's Hospital, Changsha, China.
Zeng Y; Department of Cardiology, Hunan Children's Hospital, Changsha, China.
Yang Y; Department of Pharmacy, The General Hospital of Western Theater Command of PLA, Chengdu, China.
Fan H; Department of Cardiology, Hunan Children's Hospital, Changsha, China.
Deng Y; Institute of Material Medical, College of Pharmacy, Army Medical University (Third Military Medical), Chongqing, China.
Chen W; Department of Ultrasound, Hunan Children's Hospital, Changsha, China.
Liu J; Department of Ultrasound, Hunan Children's Hospital, Changsha, China.
Yang F; Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Li W; Department of Ultrasound, Hunan Children's Hospital, Changsha, China.
Xiao Y; Department of Cardiology, Hunan Children's Hospital, Changsha, China.
Pokaż więcej
Źródło:
Epigenetics [Epigenetics] 2023 Dec; Vol. 18 (1), pp. 2242225.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hypertension, Pulmonary*/genetics
Hypertension, Pulmonary*/metabolism
Humans ; Rats ; Animals ; Familial Primary Pulmonary Hypertension/genetics ; Familial Primary Pulmonary Hypertension/metabolism ; Becaplermin/genetics ; Becaplermin/metabolism ; Pulmonary Artery/metabolism ; Epigenome ; Cell Proliferation ; Myocytes, Smooth Muscle/metabolism ; DNA Methylation ; RNA, Messenger/metabolism ; Methyltransferases/genetics ; Methyltransferases/metabolism
Czasopismo naukowe
Tytuł:
Impact of selexipag use within 12 months of pulmonary arterial hypertension diagnosis on hospitalizations and medical costs: A retrospective cohort study.
Autorzy:
Tsang Y; Real-World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.
Stokes M; Data Analytics, Evidera, St-Laurent, Quebec, Canada.
Kim YJ; Data Analytics, Evidera, St-Laurent, Quebec, Canada.
Tilney R; Data Analytics, Evidera, Waltham, Massachusetts, USA.
Panjabi S; Real-World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2023 Dec; Vol. 17 (12), pp. 1209-1222. Date of Electronic Publication: 2023 Oct 07.
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*/diagnosis
Pulmonary Arterial Hypertension*/drug therapy
Hypertension, Pulmonary*/diagnosis
Hypertension, Pulmonary*/drug therapy
Hypertension, Pulmonary*/metabolism
Humans ; Antihypertensive Agents/therapeutic use ; Retrospective Studies ; Familial Primary Pulmonary Hypertension ; Hospitalization ; Disease Progression
Czasopismo naukowe
Tytuł:
Personalized Antihypertensive Treatment Optimization With Smartphone-Enabled Remote Precision Dosing of Amlodipine During the COVID-19 Pandemic (PERSONAL-CovidBP Trial).
Autorzy:
Collier DJ; William Harvey Research Institute Queen Mary University of London London UK.
Taylor M; Closed Loop Medicine London UK.
Godec T; William Harvey Research Institute Queen Mary University of London London UK.
Shiel J; William Harvey Research Institute Queen Mary University of London London UK.
James R; William Harvey Research Institute Queen Mary University of London London UK.
Chowdury Y; William Harvey Research Institute Queen Mary University of London London UK.
Ebano P; William Harvey Research Institute Queen Mary University of London London UK.
Monk V; William Harvey Research Institute Queen Mary University of London London UK.
Patel M; William Harvey Research Institute Queen Mary University of London London UK.
Pheby J; William Harvey Research Institute Queen Mary University of London London UK.
Pheby R; William Harvey Research Institute Queen Mary University of London London UK.
Foubister A; William Harvey Research Institute Queen Mary University of London London UK.
David C; William Harvey Research Institute Queen Mary University of London London UK.
Saxena M; William Harvey Research Institute Queen Mary University of London London UK.
Richardson L; Closed Loop Medicine London UK.
Siddle J; Closed Loop Medicine London UK.
Timlin G; Closed Loop Medicine London UK.
Goldsmith P; Closed Loop Medicine London UK.
Deeming N; TrialsConnect London UK.
Poulter NR; Imperial College Clinical Trials Unit, School of Public Health, Imperial College London London UK.
Gabe R; Wolfson Institute of Population Health Queen Mary University of London London UK.
McManus RJ; Nuffield Department of Primary Care Health Sciences University of Oxford Oxford UK.
Caulfield MJ; William Harvey Research Institute Queen Mary University of London London UK.
Pokaż więcej
Źródło:
Journal of the American Heart Association [J Am Heart Assoc] 2024 Feb 20; Vol. 13 (4), pp. e030749. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Hypertension*/diagnosis
Hypertension*/drug therapy
Hypertension*/chemically induced
Humans ; Adolescent ; Adult ; Antihypertensive Agents/therapeutic use ; Amlodipine/therapeutic use ; Smartphone ; Pandemics ; Pilot Projects ; Blood Pressure ; Essential Hypertension/drug therapy ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Plasma catestatin levels are related to metabolic parameters in patients with essential hypertension and type 2 diabetes mellitus.
Autorzy:
Pankova O; Department of General Practice-Family Medicine, Kharkiv National Medical University, Heroiv Kharkova Ave., 275, Kharkiv, 61106, Ukraine. .
Korzh O; Department of General Practice-Family Medicine, Kharkiv National Medical University, Heroiv Kharkova Ave., 275, Kharkiv, 61106, Ukraine.
Pokaż więcej
Źródło:
Heart and vessels [Heart Vessels] 2024 Feb; Vol. 39 (2), pp. 144-159. Date of Electronic Publication: 2023 Sep 27.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/epidemiology
Hypertension*/complications
Hypertension*/epidemiology
Insulin Resistance*
Peptide Fragments*
Chromogranin A*
Humans ; Glycated Hemoglobin ; Antihypertensive Agents ; Body Mass Index ; Essential Hypertension ; Blood Glucose/analysis
Czasopismo naukowe
Tytuł:
Pathophysiology and Treatment of Pulmonary Arterial Hypertension.
Autorzy:
Fukumoto Y; Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 18; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Editorial
MeSH Terms:
Pulmonary Arterial Hypertension*/therapy
Hypertension, Pulmonary*/therapy
Humans ; Familial Primary Pulmonary Hypertension
Opinia redakcyjna
Tytuł:
A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension.
Autorzy:
Nabeh OA; Medical Pharmacology, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt. .
Saud AI; Kasralainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Amin B; Kasralainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Khedr AS; Kasralainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Amr A; Kasralainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Faoosa AM; Kasralainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Esmat E; Kasralainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Mahmoud YM; Kasralainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Hatem A; Kasralainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Mohamed M; Kasralainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Osama A; Kasralainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Soliman YMA; Pulmonology, Pulmonary Medicine Department, Kasr Alainy Hospital, Cairo University, Cairo, Egypt.
Elkorashy RI; Pulmonology, Pulmonary Medicine Department, Kasr Alainy Hospital, Cairo University, Cairo, Egypt.
Elmorsy SA; Medical Pharmacology, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Pokaż więcej
Źródło:
American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2024 Jan; Vol. 24 (1), pp. 39-54. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Meta-Analysis; Systematic Review
MeSH Terms:
Pulmonary Arterial Hypertension*/drug therapy
Hypertension, Pulmonary*/drug therapy
Metformin*/therapeutic use
Humans ; AMP-Activated Protein Kinases/therapeutic use ; Familial Primary Pulmonary Hypertension ; Estrogens/therapeutic use
Raport
Tytuł:
Efficacy and safety of olmesartan medoxomil-amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single-arm, multi-center, real-world study.
Autorzy:
Cui Z; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Qiu Z; Department of Cardiology, Shanghai Tongren Hospital, Shanghai, China.
Cheng W; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Hu W; Department of Cardiology, Central Hospital of Minhang District, Shanghai, China.
Ma G; Department of Cardiology, Zhongda Hospital Affiliated to Southeast University, Nanjing, China.
Cai X; Department of Cardiology, Jinan Central Hospital, Jinan, China.
Jin Y; Department of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Zhao Y; Department of Cardiology, Dalian Jinzhou First People's Hospital, Dalian, China.
He L; Department of Cardiology, Wuhan No. 1 Hospital, Wuhan, China.
Li Y; Department of Cardiology, Shanghai East Hospital, Shanghai, China.
Bu P; Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.
Chen X; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Wang R; Department of Cardiology, Wuxi People's Hospital, Wuxi, China.
Chen L; Department of Cardiology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Dong P; Department of Cardiology, Beijing Aviation General Hospital, Beijing, China.
Feng L; Department of Cardiology, Shidong Hospital, Yangpu District, Shanghai, China.
Han X; Department of Cardiology, Shanxi Cardiovascular Hospital (Shanxi Cardiovascular Diseases Institute), Taiyuan, China.
Hong M; Department of Cardiology, The Second Clinical Medical College of Nanjing Medical University, Nanjing, China.
Hou Y; Department of Cardiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Liao M; Department of Cardiology, Baoshan Branch, Shanghai General Hospital, Shanghai, China.
Wang M; Department of Cardiology, Putuo People's Hospital, Tongji University, Shanghai, China.
Wang X; Department of Cardiology, Wuxi Third People's Hospital, Wuxi, China.
Xie J; Department of Cardiology, Zhejiang Provincial People's Hospital, Hangzhou, China.
Xu Y; Department of Cardiology, Shanghai Tenth People's Hospital, Shanghai, China.
Wang Z; Department of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
Huang K; Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li Y; Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, China.
Li D; Department of Cardiology, Wuhan Third Hospital, Wuhan, China.
Ji X; Department of Cardiology, Wenzhou Central Hospital, Wenzhou, China.
Huang J; Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wang J; Department of Cardiology, Jing'an District Central Hospital of Shanghai, Shanghai, China.
Fang D; Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wang J; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Tang L; Department of Cardiology, Zhejiang Hospital, Hangzhou, China.
Liu Y; Department of Cardiology, Tianjin Third Central Hospital, Tianjin, China.
Fu G; Department of Cardiology, Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Du J; Medical Department, Daiichi Sankyo (China) Holdings Co., Ltd, Shanghai, China.
Wang L; Medical Department, Daiichi Sankyo (China) Holdings Co., Ltd, Shanghai, China.
Liu M; Medical Department, Daiichi Sankyo (China) Holdings Co., Ltd, Shanghai, China.
Ge J; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Journal of clinical hypertension (Greenwich, Conn.) [J Clin Hypertens (Greenwich)] 2024 Jan; Vol. 26 (1), pp. 5-16. Date of Electronic Publication: 2023 Sep 04.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension*/drug therapy
Hypertension*/epidemiology
Hypertension*/chemically induced
Amlodipine Besylate, Olmesartan Medoxomil Drug Combination*
Leukemia, Myeloid, Acute*/chemically induced
Leukemia, Myeloid, Acute*/drug therapy
Sulfonamides*
Humans ; Olmesartan Medoxomil/pharmacology ; Amlodipine/adverse effects ; Hydrochlorothiazide/therapeutic use ; Tetrazoles/pharmacology ; Imidazoles/adverse effects ; Drug Therapy, Combination ; Double-Blind Method ; Antihypertensive Agents/adverse effects ; Blood Pressure/physiology ; Essential Hypertension/drug therapy
Czasopismo naukowe
Tytuł:
Results of atrial flow regulator implantation in pulmonary arterial hypertension patients with severe heart failure despite maximal medical therapy.
Autorzy:
Kopeć G; Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital in Krakow, Kraków, Poland. .
Araszkiewicz A; 1st Department of Cardiology, University of Medical Sciences, Poznań, Poland.
Magoń W; Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital in Krakow, Kraków, Poland.; Department of Medical Education, Jagiellonian University Medical College, Kraków, Poland.
Stępniewski J; Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital in Krakow, Kraków, Poland.; Department of Medical Education, Jagiellonian University Medical College, Kraków, Poland.
Sławek-Szmyt S; 1st Department of Cardiology, University of Medical Sciences, Poznań, Poland.
Janus M; 1st Department of Cardiology, University of Medical Sciences, Poznań, Poland.
Skoczylas I; 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
Gąsior Z; Department of Cardiology, School of Health Sciences, Medical University of Silesia in Katowice, Katowice, Poland.
Wilczek Ł; Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital in Krakow, Kraków, Poland.
Komar M; Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital in Krakow, Kraków, Poland.
Gackowski A; Department of Coronary Artery Disease and Heart Failure, Jagiellonian University Medical College, John Paul II Hospital, Kraków, Poland.
Sabiniewicz A; Department of Pediatric Cardiology and Congenital Heart Disease, Medical University of Gdansk, Gdańsk, Poland.
Pokaż więcej
Źródło:
Kardiologia polska [Kardiol Pol] 2024; Vol. 82 (1), pp. 75-78. Date of Electronic Publication: 2023 Aug 04.
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*/drug therapy
Pulmonary Arterial Hypertension*/surgery
Hypertension, Pulmonary*/drug therapy
Hypertension, Pulmonary*/surgery
Heart Failure*/surgery
Humans ; Familial Primary Pulmonary Hypertension ; Heart Atria
Czasopismo naukowe
Tytuł:
Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
Autorzy:
Lun X; Ji'nan Zhangqiu District Hospital of Traditional Chinese Medicine, Jinan City, China.
Yang J; First Clinical Medical College, Shandong university of traditional Chinese medicine, Jinan City, China.
Liu Y; Rheumatology and immunology Department, The affiliated hospital of Shandong university of traditional Chinese medicine, Jinan City, China.
Zhao F; Guanghua Clinical Medical College, Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wei Z; Radiological department, Shanghe county hospital of traditional Chinese medicine, Jinan City, China.
Sun Y; First Clinical Medical College, Shandong university of traditional Chinese medicine, Jinan City, China.
Zhou X; Rheumatology and immunology Department, The affiliated hospital of Shandong university of traditional Chinese medicine, Jinan City, China.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2023 Dec 22; Vol. 102 (51), pp. e36654.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Pulmonary Arterial Hypertension*/etiology
Pulmonary Arterial Hypertension*/complications
Hypertension, Pulmonary*/epidemiology
Hypertension, Pulmonary*/etiology
Hypertension, Pulmonary*/diagnosis
Serositis*/complications
Pericardial Effusion*
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/epidemiology
Lupus Erythematosus, Systemic*/diagnosis
Raynaud Disease*/complications
Raynaud Disease*/epidemiology
Vasculitis*/complications
Humans ; Cohort Studies ; Rheumatoid Factor ; Familial Primary Pulmonary Hypertension/complications ; Risk Factors
Czasopismo naukowe
Tytuł:
From the microscopic to the macroscopic: clinical-radiological-pathological correlation in pulmonary hypertension.
Autorzy:
Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK .; Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.; National Institute for Health and Care Research Sheffield Biomedical Research Centre, Sheffield, UK.
Dorfmüller P; Department of Pathology, University Hospital of Giessen and Marburg, Giessen, Germany.; Institute for Lung Health, Giessen, Germany.
Gopalan D; Department of Radiology, Imperial College Healthcare NHS Trust, London, UK.
Sitbon O; INSERM UMR_S 999, Hôpital Marie-Lannelongue, Le Plessis-Robinson, France.; Faculté Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France.; Service de Pneumologie et Soins Intensifs Respiratoires, Centre de Référence de l'Hypertension Pulmonaire, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Vonk Noordegraaf A; Pulmonology, Amsterdam UMC, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2023 Dec 20; Vol. 32 (170). Date of Electronic Publication: 2023 Dec 20 (Print Publication: 2023).
Typ publikacji:
Editorial; Comment
MeSH Terms:
Hypertension, Pulmonary*/diagnostic imaging
Pulmonary Arterial Hypertension*
Humans ; Tomography, X-Ray Computed ; Familial Primary Pulmonary Hypertension
Opinia redakcyjna
Tytuł:
Clinical-radiological-pathological correlation in pulmonary arterial hypertension.
Autorzy:
Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK .; Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.; National Institute for Health and Care Research Sheffield Biomedical Research Centre, Sheffield, UK.; These authors contributed equally to this work.
Durrington C; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.
Hameed A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.
Lewis RA; Department of Respiratory Medicine, Middlemore Hospital, Auckland, New Zealand.
Venkateswaran R; Department of Heart and Lung Transplantation, Manchester University NHS Foundation Trust, Manchester, UK.
Gopalan D; Department of Radiology, Imperial College Healthcare NHS Trust, London, UK.; These authors contributed equally to this work.
Dorfmüller P; Department of Pathology, University Hospital of Giessen and Marburg, Giessen, Germany.; Institute for Lung Health, Giessen, Germany.; These authors contributed equally to this work.
Pokaż więcej
Źródło:
European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2023 Dec 20; Vol. 32 (170). Date of Electronic Publication: 2023 Dec 20 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*/diagnosis
Humans ; Familial Primary Pulmonary Hypertension ; Pulmonary Artery/diagnostic imaging
Czasopismo naukowe
Tytuł:
Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension.
Autorzy:
Singh N; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
Eickhoff C; Department of Computer Science, Brown University, Providence, RI, USA.
Garcia-Agundez A; Brown Center for Biomedical Informatics, Brown University, Providence, RI, USA.
Bertone P; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
Paudel SS; Department of Physiology and Cell Biology, College of Medicine, University of South Alabama, Mobile, AL, USA.; Center for Lung Biology, College of Medicine, University of South Alabama, Mobile, AL, USA.
Tambe DT; Center for Lung Biology, College of Medicine, University of South Alabama, Mobile, AL, USA.; Department of Pharmacology, College of Medicine, University of South Alabama, Mobile, AL, USA.; Department of Mechanical Aerospace and Biomedical Engineering, College of Engineering, University of South Alabama, Mobile, AL, USA.
Litzky LA; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Cox-Flaherty K; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
Klinger JR; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
Monaghan SF; Department of Surgery, Alpert Medical School of Brown University, Providence, RI, USA.
Mullin CJ; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
Pereira M; Lifespan Hospital System, Providence, RI, USA.
Walsh T; Lifespan Hospital System, Providence, RI, USA.
Whittenhall M; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
Stevens T; Department of Physiology and Cell Biology, College of Medicine, University of South Alabama, Mobile, AL, USA.; Center for Lung Biology, College of Medicine, University of South Alabama, Mobile, AL, USA.
Harrington EO; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.; Vascular Research Laboratory, Providence Veterans Affairs Medical Center, Providence, RI, USA.
Ventetuolo CE; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA. corey_.; Department of Health Services, Policy and Practice, Brown University, Providence, RI, USA. corey_.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 18; Vol. 13 (1), pp. 22534. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension, Pulmonary*/pathology
Pulmonary Arterial Hypertension*/pathology
Vascular Diseases*/pathology
Humans ; Pulmonary Artery/pathology ; Endothelial Cells/metabolism ; Familial Primary Pulmonary Hypertension/metabolism ; Wnt Signaling Pathway/genetics
Czasopismo naukowe
Tytuł:
Relationship between β 1-AA and AT1-AA and Cardiac Function in Patients with Hypertension Complicated with Left Ventricular Diastolic Function Limitation.
Autorzy:
Wang L; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Lv XB; Third Medical Center, The General Hospital of the People's Liberation Army, Beijing 100039, China.
Yuan YT; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Wang N; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Yao HY; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Zhang WC; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Yin PF; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Liu XH; Department of Cardiology, Peking University International Hospital, Beijing 102206, China.
Pokaż więcej
Źródło:
Cardiovascular therapeutics [Cardiovasc Ther] 2023 Dec 13; Vol. 2023, pp. 7611819. Date of Electronic Publication: 2023 Dec 13 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension*/complications
Hypertension*/diagnosis
Hypertension*/drug therapy
Ventricular Dysfunction, Left*/diagnosis
Cardiomyopathies*/complications
Humans ; Autoantibodies ; Ventricular Function, Left ; Essential Hypertension/complications ; Essential Hypertension/diagnosis
Czasopismo naukowe
Tytuł:
Transpulmonary Expression of Exosomal microRNAs in Idiopathic and Congenital Heart Disease-Related Pulmonary Arterial Hypertension.
Autorzy:
Chang WT; School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease National Sun Yat-sen University Kaohsiung Taiwan.; Division of Cardiology, Department of Internal Medicine Chi Mei Medical Center Tainan Taiwan.
Lee WC; Division of Cardiology, Department of Internal Medicine Chi Mei Medical Center Tainan Taiwan.; School of Medicine, College of Medicine National Sun Yat-sen University Kaohsiung Taiwan.
Lin YW; Division of Cardiology, Department of Internal Medicine Chi Mei Medical Center Tainan Taiwan.
Shih JY; Division of Cardiology, Department of Internal Medicine Chi Mei Medical Center Tainan Taiwan.; School of Medicine, College of Medicine National Sun Yat-sen University Kaohsiung Taiwan.
Hong CS; Division of Cardiology, Department of Internal Medicine Chi Mei Medical Center Tainan Taiwan.; Department of Health and Nutrition Chia Nan University of Pharmacy and Science Tainan Taiwan.
Chen ZC; Division of Cardiology, Department of Internal Medicine Chi Mei Medical Center Tainan Taiwan.; School of Medicine, College of Medicine National Sun Yat-sen University Kaohsiung Taiwan.
Chu CY; Division of Cardiology, Department of Internal Medicine Kaohsiung Medical University Hospital Kaohsiung Taiwan.
Hsu CH; Division of Critical Care, Department of Internal Medicine National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan.
Pokaż więcej
Źródło:
Journal of the American Heart Association [J Am Heart Assoc] 2023 Dec 05; Vol. 12 (23), pp. e031435. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
MicroRNAs*/metabolism
Pulmonary Arterial Hypertension*/genetics
Pulmonary Arterial Hypertension*/metabolism
Heart Defects, Congenital*/metabolism
Humans ; Endothelial Cells/metabolism ; Familial Primary Pulmonary Hypertension/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies